Alexandra Grant

Primary Focus & Experience

Alexandra has extensive experience of advising both lenders and sponsors/borrowers on a wide range of complex and cross-border leveraged acquisition, public to private, and infrastructure financings and restructurings, across the full spectrum of products (including bank/bond, covenant-lite, second lien, mezzanine, private high yield and holdco PIK).

She has advised on some of the largest and most significant transactions in the European market, with recent experience including:

• Advising a group of 10 private credit funds on the £1.25 billion financing for EQT’s £4.6 billion cash offer to acquire Dechra Pharma plc, in what would be one of the biggest UK takeover deals this year.
• Advising Cedacri S.p.A. (the “Issuer”) in connection with its issuance of €275 million senior secured floating rate notes due 2028.
• Advising General Atlantic on the intended combination of Qontigo and ISS (both majority-owned by Deutsche Börse), with General Atlantic becoming the sole minority shareholder of the combined Qontigo entity. 
• Advising the initial purchasers, placement agents and lenders in connection with the offering and placement by Italmatch Chemicals S.p.A. (a Bain Capital portfolio company) of €690 million in aggregate principal amount of senior secured notes due 2028 and the amendment and maturity extension of its existing revolving credit facility. 
• Advising Carlyle as sponsor on the €525 million financing for hospital operator AMEOS Gruppe, used to refinance AMEOS Gruppe’s existing senior debt and for a dividend recapitalisation.
• Advising lenders and agents in the provision of a £425 million term facility, £50 million term acquisition facility, and £60 million super senior revolving credit facility for Bridgepoint Capital’s acquisition of the Zenith Group and the add-on acquisition of the Contract Vehicles group.
• Advising lenders on their privately placed second lien financing for KKR’s acquisition of Exact Software.
• Advising lenders on the €270m refinancing for Colosseum Dental Group (a Jacobs’ portfolio company).
• Advising revolving credit facility banks and credit funds on the financing for Bain’s acquisition of Bugaboo.
• Advising mandated lead arrangers on the €500m bridge and revolving facility financing for Victoria PLC.
• Advising mandated lead arrangers on (i) €555m bridge to bond and revolving facility financing for Bain’s acquisition of Fedrigoni, and (ii) €500M bridge to bond and revolving facility financing for Bain’s acquisition of Italmach Chemicals.

Recognition & Accomplishments

Alexandra has been recognized as Band 6 in Chambers UK 2024 in Banking & Finance and as a “Next Generation Partner” in Legal 500 UK 2024. 

Alexandra Grant is noted for her work on cross-border leveraged finance matters, with particular expertise in infrastructure financing. She regularly acts on behalf of international investment and merchant banks.

"Alex is always an outstanding lawyer."

“Alexandra Grant provides excellent advice – she is supportive and helpful to all members of our team, they are collegiate and will quickly find the right person to answer questions.”

"She is very efficient, bright and knows the points."

"Alexandra is detail-oriented and proactive."

“Alexandra is very efficient and bright; she knows the points. She is smart."

“Alexandra Grant has great knowledge of the area and potential loopholes in financial agreements and is a good presence to have on our side when negotiating vis-à-vis sponsor counsel.”

“She is active and well regarded.”

(Client Testimonials, Chambers and Legal 500)

Alexandra has also acted as contributing editor to Chambers & Partners Global Practice Guides: Banking & Finance 2020 and 2021.

In 2014 she completed a 7-month secondment to Goldman Sachs’ Leveraged Finance Capital Markets team in London.